Continuous 24-hour intravenous infusion of recombinant human growth hormone (GH)-releasing hormone-(1-44)-amide augments pulsatile, entropic, and daily rhythmic GH secretion in postmenopausal women equally in the estrogen-withdrawn and estrogen-supplemented states

How estrogen amplifies GH secretion in the human is not known. The present study tests the clinical hypothesis that estradiol modulates the stimulatory actions of a primary GH feedforward signal, GHRH. To this end, we investigated the ability of short-term (7- to 12-day) supplementation with oral es...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:The journal of clinical endocrinology and metabolism Ročník 86; číslo 2; s. 700
Hlavní autoři: Evans, W S, Anderson, S M, Hull, L T, Azimi, P P, Bowers, C Y, Veldhuis, J D
Médium: Journal Article
Jazyk:angličtina
Vydáno: United States 01.02.2001
Témata:
ISSN:0021-972X
On-line přístup:Zjistit podrobnosti o přístupu
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract How estrogen amplifies GH secretion in the human is not known. The present study tests the clinical hypothesis that estradiol modulates the stimulatory actions of a primary GH feedforward signal, GHRH. To this end, we investigated the ability of short-term (7- to 12-day) supplementation with oral estradiol vs. placebo to modulate basal, pulsatile, entropic, and 24-h rhythmic GH secretion driven by a continuous iv infusion of recombinant human GHRH-(1--44)-amide vs. saline in nine healthy postmenopausal women. Volunteers underwent concurrent blood sampling every 10 min for 24 h on four occasions in a prospectively randomized, single blind, within-subject cross-over design (placebo/saline, placebo/GHRH, estradiol/saline, estradiol/GHRH). Intensively sampled serum GH concentrations were quantitated by ultrasensitive chemiluminescence assay. Basal, pulsatile, entropic (feedback-sensitive), and 24-h rhythmic modes of GH secretion were appraised by deconvolution analysis, the approximate entropy (ApEn) statistic, and cosine regression, respectively. ANOVA revealed that continuous iv infusion of GHRH in the estrogen-withdrawn (control) milieu 1) amplified individual basal (P = 0.00011) and pulsatile (P < 10(-13)) GH secretion rates by 12- and 11-fold, respectively; 2) augmented GH secretory burst mass and amplitude each by 10-fold (P < 10(-11)), without altering GH secretory burst frequency, duration, or half-life; 3) increased the disorderliness (ApEn) of GH release patterns (P = 0.0000002); 4) elevated the mesor (cosine mean) and amplitude of the 24-h rhythm in serum GH concentrations by nearly 30-fold (both P < 10(-12)); 5) induced a phase advance in the clocktime of the GH zenith (P = 0.021); and 6) evoked a new 24-h rhythm in GH secretory burst mass with a maximum at 0018 h GH (P < 10(-3)), while damping the mesor of the 24-h rhythm in GH interpulse intervals (P < 0.025). Estradiol supplementation alone 1) increased the 24-h mean and integrated serum GH concentration (P = 0.047); 2) augmented GH secretory burst mass (P: = 0.025) without influencing pulse frequency, duration, half-life, or basal secretion; 2) stimulated more irregular patterns of GH release (higher ApEn; P = 0.012); and 3) elevated the 24-h rhythmic GH mesor (P = 0.0005), but not amplitude. Notably, combined stimulation of the GH axis with GHRH-(1--44)-amide and estradiol exerted no further effect beyond that evoked by GHRH alone, except for normalizing the acrophase of 24-h GH rhythmic release and elevating the postinfusion plasma insulin-like growth factor I concentration (P = 0.016). Unexpectedly, the two GHRH-infused serum GH concentration profiles monitored after placebo and estradiol pretreatment showed strongly nonrandom synchrony with a 20- to 30-min lag (P < 0.001). In summary, the present clinical investigations unmask a 3-fold (pulsatile, entropic, and daily rhythmic) similitude between the neuroregulatory actions of estradiol and GHRH in healthy postmenopausal women. However, GHRH infusion was multifold more effectual than estradiol, and only GHRH elevated nonpulsatile (basal) GH secretion, shifted the GH acrophase, and synchronized GH profiles. Given the nonadditive nature of the joint effects of estradiol and GHRH on pulsatile and entropic GH release, we hypothesize that estrogen amplifies GH secretion in part by enhancing endogenous GHRH release or actions. In addition, the distinctive ability of GHRH (but not estradiol) to increase basal (nonpulsatile) GH secretion, shift the GH acrophase and synchronize GH output patterns identifies certain divergent hypothalamo-pituitary actions of these two major GH secretagogues.
AbstractList How estrogen amplifies GH secretion in the human is not known. The present study tests the clinical hypothesis that estradiol modulates the stimulatory actions of a primary GH feedforward signal, GHRH. To this end, we investigated the ability of short-term (7- to 12-day) supplementation with oral estradiol vs. placebo to modulate basal, pulsatile, entropic, and 24-h rhythmic GH secretion driven by a continuous iv infusion of recombinant human GHRH-(1--44)-amide vs. saline in nine healthy postmenopausal women. Volunteers underwent concurrent blood sampling every 10 min for 24 h on four occasions in a prospectively randomized, single blind, within-subject cross-over design (placebo/saline, placebo/GHRH, estradiol/saline, estradiol/GHRH). Intensively sampled serum GH concentrations were quantitated by ultrasensitive chemiluminescence assay. Basal, pulsatile, entropic (feedback-sensitive), and 24-h rhythmic modes of GH secretion were appraised by deconvolution analysis, the approximate entropy (ApEn) statistic, and cosine regression, respectively. ANOVA revealed that continuous iv infusion of GHRH in the estrogen-withdrawn (control) milieu 1) amplified individual basal (P = 0.00011) and pulsatile (P < 10(-13)) GH secretion rates by 12- and 11-fold, respectively; 2) augmented GH secretory burst mass and amplitude each by 10-fold (P < 10(-11)), without altering GH secretory burst frequency, duration, or half-life; 3) increased the disorderliness (ApEn) of GH release patterns (P = 0.0000002); 4) elevated the mesor (cosine mean) and amplitude of the 24-h rhythm in serum GH concentrations by nearly 30-fold (both P < 10(-12)); 5) induced a phase advance in the clocktime of the GH zenith (P = 0.021); and 6) evoked a new 24-h rhythm in GH secretory burst mass with a maximum at 0018 h GH (P < 10(-3)), while damping the mesor of the 24-h rhythm in GH interpulse intervals (P < 0.025). Estradiol supplementation alone 1) increased the 24-h mean and integrated serum GH concentration (P = 0.047); 2) augmented GH secretory burst mass (P: = 0.025) without influencing pulse frequency, duration, half-life, or basal secretion; 2) stimulated more irregular patterns of GH release (higher ApEn; P = 0.012); and 3) elevated the 24-h rhythmic GH mesor (P = 0.0005), but not amplitude. Notably, combined stimulation of the GH axis with GHRH-(1--44)-amide and estradiol exerted no further effect beyond that evoked by GHRH alone, except for normalizing the acrophase of 24-h GH rhythmic release and elevating the postinfusion plasma insulin-like growth factor I concentration (P = 0.016). Unexpectedly, the two GHRH-infused serum GH concentration profiles monitored after placebo and estradiol pretreatment showed strongly nonrandom synchrony with a 20- to 30-min lag (P < 0.001). In summary, the present clinical investigations unmask a 3-fold (pulsatile, entropic, and daily rhythmic) similitude between the neuroregulatory actions of estradiol and GHRH in healthy postmenopausal women. However, GHRH infusion was multifold more effectual than estradiol, and only GHRH elevated nonpulsatile (basal) GH secretion, shifted the GH acrophase, and synchronized GH profiles. Given the nonadditive nature of the joint effects of estradiol and GHRH on pulsatile and entropic GH release, we hypothesize that estrogen amplifies GH secretion in part by enhancing endogenous GHRH release or actions. In addition, the distinctive ability of GHRH (but not estradiol) to increase basal (nonpulsatile) GH secretion, shift the GH acrophase and synchronize GH output patterns identifies certain divergent hypothalamo-pituitary actions of these two major GH secretagogues.
Author Anderson, S M
Azimi, P P
Evans, W S
Hull, L T
Bowers, C Y
Veldhuis, J D
Author_xml – sequence: 1
  givenname: W S
  surname: Evans
  fullname: Evans, W S
  organization: Division of Endocrinology, Department of Internal Medicine, University of Virginia School of Medicine, Charlottesville, Virginia 22908-0202, USA
– sequence: 2
  givenname: S M
  surname: Anderson
  fullname: Anderson, S M
– sequence: 3
  givenname: L T
  surname: Hull
  fullname: Hull, L T
– sequence: 4
  givenname: P P
  surname: Azimi
  fullname: Azimi, P P
– sequence: 5
  givenname: C Y
  surname: Bowers
  fullname: Bowers, C Y
– sequence: 6
  givenname: J D
  surname: Veldhuis
  fullname: Veldhuis, J D
BackLink https://www.ncbi.nlm.nih.gov/pubmed/11158034$$D View this record in MEDLINE/PubMed
BookMark eNo9kc1r20AQxVVIqJO0p97LHBPIururlSUfi2ntQiCXBHoLs6uRtUHaVfcjxv995SbpaXjvMT8evMvizHlHRfFF8KWQgn97NstmtZTLmvOz4oJzKdi6lr8XxWWMz5wLparyY7EQQlQNL9XFh8XGu2Rd9jmCVKz3OYB1KeALuZNnXZej9Q58B4GMH7V16BL0eUQH--APqYfeh3HuAdfb3Q0LNBBG6_bvNrsWTKkbhqNtCTDvR3IpwpSHiMkOdAuzDn6y5hbQtdCiHY4Q-mPqR2tgu4NIJlA6tbAOJh_TTPAT5ogDHPwsgP5kHOavOU89AcUZuCfHDjb1bcCD-0f-b8c8TQOdelALMWGi-Kk473CI9PntXhWPP388bHbs7n77a_P9jhnZyMTISEPrTmshVIdKKYGITVmqrjarSuOc605qTV1TVpprZdaNaupyVbWG142SV8XXV-6U9Ujt0xTsiOH49D6J_Asx3JUM
CitedBy_id crossref_primary_10_1007_s11102_007_0045_7
crossref_primary_10_1016_S0197_4580_03_00058_7
crossref_primary_10_1089_109454502317629327
crossref_primary_10_1159_000071232
crossref_primary_10_1016_S1096_6374_01_80005_8
crossref_primary_10_1089_10945450152466215
crossref_primary_10_1111_j_1365_2265_2005_02294_x
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
DOI 10.1210/jc.86.2.700
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
ExternalDocumentID 11158034
Genre Research Support, U.S. Gov't, P.H.S
Journal Article
Comparative Study
GrantInformation_xml – fundername: NIA NIH HHS
  grantid: R01-AG-14799-01
– fundername: NCRR NIH HHS
  grantid: MO1-RR-00847
GroupedDBID ---
-~X
.55
.GJ
.XZ
08P
0R~
18M
1TH
29K
2WC
34G
354
39C
3O-
3V.
4.4
48X
53G
5GY
5RS
5YH
7X7
88E
8F7
8FI
8FJ
AABZA
AACZT
AAIMJ
AAJQQ
AAKAS
AAPGJ
AAPQZ
AAPXW
AAQQT
AARHZ
AAUAY
AAUQX
AAVAP
AAWDT
AAWTL
AAYJJ
ABBLC
ABDFA
ABDPE
ABEJV
ABGNP
ABJNI
ABLJU
ABMNT
ABNHQ
ABOCM
ABPMR
ABPPZ
ABPQP
ABPTD
ABQNK
ABUWG
ABVGC
ABWST
ABXVV
ACFRR
ACGFO
ACGFS
ACPRK
ACUTJ
ACYHN
ACZBC
ADBBV
ADGKP
ADGZP
ADHKW
ADQBN
ADRTK
ADVEK
ADZCM
AELWJ
AEMDU
AENEX
AENZO
AERZD
AETBJ
AEWNT
AFCHL
AFFNX
AFFQV
AFFZL
AFGWE
AFKRA
AFOFC
AFRAH
AFXAL
AFYAG
AGINJ
AGKRT
AGMDO
AGQXC
AGUTN
AHMBA
AHMMS
AI.
AJEEA
ALMA_UNASSIGNED_HOLDINGS
APIBT
APJGH
AQDSO
AQKUS
ARIXL
ASPBG
ATGXG
AVWKF
AZFZN
BAWUL
BAYMD
BCRHZ
BENPR
BEYMZ
BPHCQ
BSWAC
BTRTY
BVXVI
C45
CCPQU
CDBKE
CGR
CS3
CUY
CVF
D-I
DAKXR
DIK
E3Z
EBS
ECM
EIF
EIHJH
EJD
EMOBN
ENERS
F5P
FECEO
FEDTE
FHSFR
FLUFQ
FOEOM
FOTVD
FQBLK
FYUFA
GAUVT
GJXCC
GX1
H13
HMCUK
HVGLF
HZ~
H~9
IAO
IHR
INH
ITC
J5H
KBUDW
KOP
KQ8
KSI
KSN
L7B
M1P
M5~
MBLQV
MHKGH
MJL
N4W
N9A
NLBLG
NOMLY
NOYVH
NPM
NVLIB
O9-
OAUYM
OBH
OCB
ODMLO
OFXIZ
OGEVE
OHH
OJZSN
OK1
OPAEJ
OVD
OVIDX
P2P
P6G
PQQKQ
PROAC
PSQYO
REU
ROX
ROZ
TEORI
TJX
TLC
TMA
TR2
TWZ
UKHRP
VH1
VVN
VXZ
W8F
WHG
WOQ
X52
X7M
YBU
YFH
YHG
YOC
YSK
ZGI
ZXP
ZY1
~02
~H1
ID FETCH-LOGICAL-c282t-ec2ce9fbb114fa4441aaa8334f7c65baec2bf2bbef835b0b4c98487365dc07842
ISICitedReferencesCount 39
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000167004900044&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 0021-972X
IngestDate Wed Feb 19 01:33:45 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 2
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c282t-ec2ce9fbb114fa4441aaa8334f7c65baec2bf2bbef835b0b4c98487365dc07842
PMID 11158034
ParticipantIDs pubmed_primary_11158034
PublicationCentury 2000
PublicationDate 2001-02-01
PublicationDateYYYYMMDD 2001-02-01
PublicationDate_xml – month: 02
  year: 2001
  text: 2001-02-01
  day: 01
PublicationDecade 2000
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle The journal of clinical endocrinology and metabolism
PublicationTitleAlternate J Clin Endocrinol Metab
PublicationYear 2001
SSID ssj0014453
Score 1.831913
Snippet How estrogen amplifies GH secretion in the human is not known. The present study tests the clinical hypothesis that estradiol modulates the stimulatory actions...
SourceID pubmed
SourceType Index Database
StartPage 700
SubjectTerms Aged
Circadian Rhythm - drug effects
Circadian Rhythm - physiology
Entropy
Estradiol - pharmacology
Estrogen Replacement Therapy
Female
Growth Hormone-Releasing Hormone - administration & dosage
Growth Hormone-Releasing Hormone - analogs & derivatives
Growth Hormone-Releasing Hormone - pharmacology
Half-Life
Human Growth Hormone - blood
Human Growth Hormone - secretion
Humans
Infusions, Intravenous
Middle Aged
Models, Biological
Peptide Fragments - administration & dosage
Peptide Fragments - pharmacology
Placebos
Postmenopause - blood
Postmenopause - physiology
Recombinant Proteins - administration & dosage
Recombinant Proteins - pharmacology
Regression Analysis
Title Continuous 24-hour intravenous infusion of recombinant human growth hormone (GH)-releasing hormone-(1-44)-amide augments pulsatile, entropic, and daily rhythmic GH secretion in postmenopausal women equally in the estrogen-withdrawn and estrogen-supplemented states
URI https://www.ncbi.nlm.nih.gov/pubmed/11158034
Volume 86
WOSCitedRecordID wos000167004900044&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF4aQBUXxKu80R5AapVulDjr1zFCkBygqkSB3qpd29tYSmwrTkrLr2dmH7ZJAcGBSxTtJBs789nz8DczhLxWkQrGQeyzEZgvxv2hZEKFPuOR8FIVjsMoSfSwifDoKDo9jY93el9cLczFIiyK6PIyrv6rqmENlI2ls_-g7mZTWID3oHR4BbXD618pHvtN5cUGqa0eZ3P4CvaEwClDuhsr_MSmtl4iRsNLqbkwdljfOUTl63l_Dp5sadzP6eyNFzMcrSJ0WsGKGDZ4YpyjUCzzNOuLzbkpl6s2C6QIGZ4yJo_LKk8cSzQVmE9Zza_Wc2TlT2f9Gh1XR7msyhpp7xDJb2oAj-4P0c-w8nNx5SiZYMdWJZw-wxxyuhLfDJ-6Wa5xUKnOeoIzrQum6q4LjhdGp19GUxqaFWkJt9CibUq1zNZwiSxck8Vu3PG1TRlPdHmQIS986iSXN-aBzoeWhj75ni81eeLYVtW5bMvIEbRbC4KUllCPgG8siG3mnXcCeWMOQt2F9bqZgjgbzVQyiIKBN9j6FMCpWmpwgh3yo6FJ9v5ZutUz3Il6pBcGaK6OMIdln61xbnuz2jOxVatYy9U5Iuyma3fZiri053Vyj9y1IROdGKjfJztZ8YDsfrSkkIc3dlvEU4t42kE8dYinpaIdxFONeGoQTy2s6f50dtCi3S2zfcT6gUE6dUinDdIPqcP5IQXkUI1y6lBOpzPaoBwOh_6McqpRTi3KUQ4op9dRrnf-JcqpQfkj8vn9u5O3M2YHnLDEi7w1yxIvyWIl5WjEleAQmQghovGYqzAJfClALpUnZaYgTpJDyZM44lE4Dvw0Adeee3vkZgF_whNCU5nFQZiOsOyXe0LJIWwjI8G9FDzOTD0lj40OzyrTxebMaffZbyXPyZ32EnhBbim4Q2Yvye3kYp3Xq1caVT8AD4Dq5Q
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Continuous+24-hour+intravenous+infusion+of+recombinant+human+growth+hormone+%28GH%29-releasing+hormone-%281-44%29-amide+augments+pulsatile%2C+entropic%2C+and+daily+rhythmic+GH+secretion+in+postmenopausal+women+equally+in+the+estrogen-withdrawn+and+estrogen-supplemented+states&rft.jtitle=The+journal+of+clinical+endocrinology+and+metabolism&rft.au=Evans%2C+W+S&rft.au=Anderson%2C+S+M&rft.au=Hull%2C+L+T&rft.au=Azimi%2C+P+P&rft.date=2001-02-01&rft.issn=0021-972X&rft.volume=86&rft.issue=2&rft.spage=700&rft_id=info:doi/10.1210%2Fjc.86.2.700&rft_id=info%3Apmid%2F11158034&rft_id=info%3Apmid%2F11158034&rft.externalDocID=11158034
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-972X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-972X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-972X&client=summon